Goncalo Saldanha

Dr. Goncalo Saldanha


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 May 2024 in Cureus
Verified
Journal Article
Open access
PDF file
GSGoncalo Saldanha
Goncalo Saldanha
SASofia Carralas Antunes
Sofia Carralas Antunes
JCJoão Cruz
João Cruz
MRMiguel Ramalho
Miguel Ramalho
Percutaneous liver biopsy, although considered a safe procedure, can lead to tumoral needle tract seeding. We describe a case of a 65-year-old woman with a history of hepatocellular carcinoma (HCC) who presented with a painless abdominal lump 15 years post-liver biopsy and left hepatectomy. An MRI revealed an abdominal wall mass suggestive of HCC metastasis from needle tract seeding. Surgical removal confirmed a well-differentiated HCC. Distinctive imaging features of HCC in specific clinical settings reduce the need for biopsy, which should be limited to exceptional cases.

8 April 2025 in Applied Sciences
Verified
Journal Article
Open access
PDF file
BGBernardo Brás Gonçalves
Bernardo Brás Gonçalves
GSGoncalo Saldanha
Goncalo Saldanha
MRMiguel Ramalho
Miguel Ramalho
AVAna Luísa Vieira
Ana Luísa Vieira
PVPedro M. Vieira
Pedro M. Vieira
Adrenal lesions are common findings in abdominal imaging, with adrenal adenomas being the most frequent type. Accurate detection of adrenal adenomas is essential to avoid unnecessary diagnostic procedures and treatments. However, conventional imaging-based evaluation relies heavily on the expertise of radiologists and can be complicated by pseudo-lesions, overlapping imaging features, and suboptimal imaging techniques. To address these challenges, we propose an end-to-end machine learning pipeline that integrates deep learning-based lesion detection (FCOS) with an ensemble classifier for adrenal lesion classification in MRI. Our pipeline operates directly on broader regions of interest, eliminating the need for manual lesion segmentation. Our method was evaluated on a multi-sequence MRI dataset comprising 206 adenomas and 45 non-adenomas. The pipeline achieved 87.45% accuracy, 87.33% specificity, and 87.63% recall for adenoma classification, demonstrating competitive performance compared to prior studies. The results highlight strong non-adenoma identification while maintaining robust adenoma detection. Future research should focus on dataset expansion, external validation, and comparison with radiologist performance to further validate clinical applicability.